High Vista Strategies LLC Xenon Pharmaceuticals Inc. Transaction History

High Vista Strategies LLC

$242 Million
Q4 2024

A detailed history of High Vista Strategies LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 66,788 shares of XENE stock, worth $2.63 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

66,788

Previous 73,762 9.45%

Holding current value

$2.63 Million

Previous $2.9 Million 9.79%

% of portfolio

1.08%

Previous 1.14%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$38.14 - $45.74 $265,988 - $318,990	-6,974 Reduced 9.45%	66,788 $2.62 Million
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $37,817 - $46,026	1,047 Added 1.44%	73,762 $2.9 Million
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $892,191 - $1.05 Million	20,914 Added 40.37%	72,715 $3.13 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $474,870 - $768,727	16,546 Added 46.93%	51,801 $2.39 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $603,948 - $702,426	17,680 Added 100.6%	35,255 $1.2 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $270,532 - $338,088	-7,765 Reduced 30.64%	17,575 $676,000
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $91,510 - $109,142	2,768 Added 12.26%	25,340 $999,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $4,218 - $5,455	137 Added 0.61%	22,572 $815,000
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $141,370 - $195,384	-5,557 Reduced 19.85%	22,435 $682,000
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $875,992 - $1.16 Million	-34,914 Reduced 55.5%	27,992 $856,000
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $189,384 - $429,756	-12,140 Reduced 16.18%	62,906 $1.97 Million
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $506,532 - $662,992	34,087 Added 83.22%	75,046 $1.15 Million
Q2 2021 Aug 16, 2021	BUY	$16.81 - $20.0 $688,520 - $819,180	40,959 New	40,959 $763,000
Q4 2020 Feb 16, 2021	SELL	$9.49 - $16.04 $412,976 - $698,012	-43,517 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.82 - $13.35 $251,867 - $310,761	23,278 Added 115.02%	43,517 $482,000
Q2 2020 Aug 14, 2020	BUY	$10.21 - $14.9 $206,640 - $301,561	20,239 New	20,239 $254,000

Others Institutions Holding XENE

# of Institutions

219

Shares Held

70.4M

Call Options Held

109K

Put Options Held

2.1K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.45B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Account

High Vista Strategies LLC Xenon Pharmaceuticals Inc. Transaction History